New tracer could sharpen breast cancer scans
NCT ID NCT05226663
First seen Dec 24, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests a new radioactive tracer called [18F]FluorThanatrace (FTT) used with PET/CT scans to improve imaging of breast cancer. About 36 adults with known breast cancer will receive the tracer before standard surgery or biopsy. The goal is to see if FTT can help detect an enzyme linked to cancer growth, potentially leading to better diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Siteman Cancer Center at Washington University
St Louis, Missouri, 63110, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.